IL-17-dependent cellular immunity to collagen type V predisposes to obliterative bronchiolitis in human lung transplants
Evidence level: prospective immunological cohort; abstract-only
Immune cell responses to collagen type V, driven by IL-17 and monocytes, were linked to more frequent and more severe BOS in lung transplant recipients.
As of . Primary source: Publisher record via DOI.
Summary
The abstract describes blood cell responses to collagen type V that were monitored prospectively over seven years in lung transplant recipients. These responses were frequently present in transplant recipients but not in healthy controls or in a comparison group of patients with Goodpasture's syndrome who had received a kidney transplant. They depended on CD4 T cells and monocytes and required IL-17, TNF-alpha and IL-1 beta. Strong collagen V responses were associated with a substantially higher incidence and severity of BOS, more strongly than acute rejection, HLA mismatch or HLA antibodies. The authors suggest that alloimmunity starts lung transplant rejection, while autoimmunity to collagen V mediated by Th17 cells and monocyte or macrophage helper cells drives progressive airway obliteration. The number of patients is not stated in the abstract.
Details
- doi
- 10.1172/jci28031
- pmid
- 17965778
- authors
- Burlingham WJ, Love RB, Jankowska-Gan E, Haynes LD, Xu Q, Bobadilla JL, Meyer KC, Hayney MS, Braun RK, Greenspan DS, Gopalakrishnan B, Cai J, Brand DD, Yoshida S, Cummings OW, Wilkes DS
- journal
- Journal of Clinical Investigation
- year
- 2007
- volume
- 117
- issue
- 11
- pages
- 3498-3506
Sources and links
- Publisher record via DOI (primary)
- PubMed 17965778
Related
Links from this record
- discusses: Bronchiolitis obliterans syndrome (BOS)
- related to: Innate immune activation
Known gaps in this record
- full text not read (abstract only)
- funding statement and grant numbers
- author affiliations
- centre or centres not stated in the abstract
Information resource only. Not medical advice. Not a substitute for the care of the patient's transplant team.